Gilead Sciences (GILD) Share-based Compensation (2009 - 2026)
Gilead Sciences' Share-based Compensation came in at $231 million for Q2 2026, up 2.7% from $225 million a year earlier and up 6.0% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Share-based Compensation (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gilead Sciences reported Share-based Compensation of $909 million, up 4.2% year-over-year; for FY2025, it came in at $894 million, up 7.1% from FY2024.
- Share-based Compensation has increased in each of the last four years, with a five-year compound annual growth rate of 6.8% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $835 million in FY2024 (+9.0%), $766 million in FY2023 (+20.3%), $637 million in FY2022 (+0.3%) and $635 million in FY2021 (-1.2%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation since Q2 2018.
- Year-over-year, Share-based Compensation has increased for 15 consecutive quarters, with growth averaging 6.7% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2023 (growth of 26.9%), and the weakest in Q1 2022 (a decline of 6.5%).
- Business Quant data shows GILD's Share-based Compensation at $218 million (Q1 2026), $230 million (Q4 2025) and $230 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 170.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 231.00 Mn |
| Mar 31, 2026 | 218.00 Mn |
| Dec 31, 2025 | 230.00 Mn |
| Sep 30, 2025 | 230.00 Mn |
| Jun 30, 2025 | 225.00 Mn |
| Mar 31, 2025 | 209.00 Mn |
| Dec 31, 2024 | 222.00 Mn |
| Sep 30, 2024 | 216.00 Mn |
| Jun 30, 2024 | 210.00 Mn |
| Mar 31, 2024 | 187.00 Mn |
| Dec 31, 2023 | 201.00 Mn |
| Sep 30, 2023 | 202.00 Mn |
| Jun 30, 2023 | 198.00 Mn |
| Mar 31, 2023 | 165.00 Mn |
| Dec 31, 2022 | 174.00 Mn |
| Sep 30, 2022 | 168.00 Mn |
| Jun 30, 2022 | 165.00 Mn |
| Mar 31, 2022 | 130.00 Mn |
| Dec 31, 2021 | 159.00 Mn |
| Sep 30, 2021 | 171.00 Mn |
API Access
Gilead Sciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();